Pricing pressure in US to keep pharma companies’ growth under check Industry-The Economic Times — January 15, 2017 comments off Dr Reddy’s Lab is expected to report subdued numbers in 3QFY17, with revenue declining 6.1 per cent Y-o-Y to Rs 37.2 billion and PAT down 22.4 per cent to Rs 4.5 billion.
